A61K8/4926

Hair shaping process using fatty substances, non-silicone polymers or surfactants
11510470 · 2022-11-29 · ·

The invention relates to a cosmetic process for treating keratin fibers, preferably the hair, comprising at least the steps consisting in: a) applying to said keratin fibers a composition containing at least one substance chosen from fatty substances, non-silicone polymers and surfactants, b) applying a mechanical tension to said keratin fibers, and c) exposing said keratin fibers under mechanical tension to microwaves, at a pressure ranging from 50,000 to 250,000 Pa, in the presence of at least one solvent in vapor form on contact with the keratin fibers and without there being complete drying of the keratin fibers throughout the entire exposure to the microwaves, the solvent(s) in vapor form being entirely generated by evaporating at least one compound present, before emission of the microwaves, on contact with the keratin fibers, step a) taking place prior to step c).

Enamine compounds for absorbance of electromagnetic energy

The present invention describes compounds and uses thereof in applications relating to absorption of electromagnetic energy. Preferred compounds are double bond-containing compounds capable of absorbing electromagnetic radiation energy and having improved properties.

COMPOSITION COMPRISING A NATURAL DYE, A HYDRAZONO AND/OR AZO CATIONIC SYNTHETIC DIRECT DYE AND AN AROMATIC COMPOUND
20220362137 · 2022-11-17 ·

The present invention relates to an anhydrous composition for dyeing human keratin fibers, comprising at least one natural dye, at least one hydrazono and/or azo cationic synthetic direct dye and at least one compound of formula (I) in which Y represents a C.sub.1-C.sub.4 hydroxyalkyl group or a C.sub.1-C.sub.4 hydroxyalkyloxy radical, n denotes an integer ranging from 0 to 5, and X, which may be identical or different, represents a C.sub.1-C.sub.4 alkyl radical or a halogen. The invention also relates to a process for dyeing human keratin fibers using this composition.

##STR00001##

Cosmetic Skin Cream and Medicine
20230056606 · 2023-02-23 ·

Embodiments of the present disclosure recite medicated cosmetic skin creams containing Yel002, methods of manufacturing said creams, and methods of using said skin creams.

Oral care compositions

This application provides, among other things, novel aqueous monophasic compositions useful for combining and delivering poorly compatible ingredients, for example to deliver effective levels of cationic antibacterial agents in combination with anionic polymers, e.g. that protect against erosion and staining, by addition of a stabilizing amount of a polyamine, e.g. lysine, and methods for making and using the same.

DEODORANT COMPOSITIONS
20230053259 · 2023-02-16 ·

A deodorant stick comprising: at least about 25% of a liquid triglyceride; at least one antimicrobial; a primary structurant with a melting point of at least about 50° C.; and less than 8% of secondary structurants having a melting point of at least about 60° C.; said stick being free of an aluminum salt; and said stick having a hardness from about 80 mm.sup.∗10 to about 140 mm.sup.∗10, as measured by penetration with ASTM D-1321 needle.

Antiperspirant and deodorant compositions

A deodorant stick comprising at least 25% by weight liquid triglyceride; a primary antimicrobial having a water solubility of at most about 90 g/L at 25° C.; a fragrance composition comprising at least about 50% natural oils, essential oils, or a combination thereof; and a primary structurant with a melting point of at least 50° C.; said deodorant stick being free of an aluminum salt; and said deodorant stick having a hardness from about 70 mm*10 to about 140 mm*10, as measured by penetration with ASTM D-1321 needle.

ALDEHYDE CONJUGATES AND USES THEREOF
20220354857 · 2022-11-10 ·

The present invention provides compounds and methods of use thereof for the treatment, prevention, and/or reduction of a risk of a disease, disorder, or condition in which aldehyde toxicity is implicated in the pathogenesis, including ocular disorders, skin disorders, conditions associated with injurious effects from blister agents, and autoimmune, inflammatory, neurological and cardiovascular diseases by the use of a primary amine to scavenge toxic aldehydes, such as MDA and HNE.

FOAM COMPOSITIONS

A foaming antiperspirant or deodorant composition comprising: a. an oil in water emulsion comprising: i. a first oil phase comprising one or more emollients; ii. a second oil phase comprising one or more emollients; wherein the second oil phase emollients have at most 5% solubility in the first oil phase emollients; iii. an antiperspirant or deodorant active; iv. one or more nonionic emulsifier; and v. a fragrance; and b. at most about 15%, by weight of the composition, of a blowing agent.

Dermal composition comprising chelator and base
11491100 · 2022-11-08 · ·

The present invention relates to non-toxic consumable compositions and formulations comprising chelator and base having synergistic effects on microbial metabolism and/or growth and/or pathogenic effectors and their use to promote and maintain health in mammals. The current invention also relates to non-toxic consumable compositions comprising more than one chelator and/or more than one base. The present invention further relates to methods for selecting said chelator and base composition and methods for detecting conditions in which selected compositions may be used. The present invention relates to the synergistic compositions and methods of their use for maintaining health, promoting health and treating diseases.